MedPath

Study Evaluating CERAMENT™|G in Open Diaphyseal Tibial Fractures

Not Applicable
Completed
Conditions
Tibial Fracture
Registration Number
NCT02820363
Lead Sponsor
BONESUPPORT AB
Brief Summary

The purpose of this study is to demonstrate the safety and effectiveness of CERAMENT™\|G used in conjunction with standard-of-care treatment compared to standard-of-care treatment alone in the care of subjects with open fractures of the tibial diaphysis.

Detailed Description

CERAMENT™\|G is a resorbable, gentamicin containing ceramic bone graft indicated to fill bony voids or gaps which are not intrinsic to the stability of the bony structure and where there is risk of bacterial contamination.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
201
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Composite of absence of deep infection at fracture site, absence of secondary procedures intended to promote fracture union, and improvement in the SF-36v2 PCS.12 months

Absence of secondary procedures, absence of infection.

Serious device related adverse events12 months

for the test (CERAMENT™\|G) arm

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (31)

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

University of California

🇺🇸

Irvine, California, United States

University of Southern California

🇺🇸

Los Angeles, California, United States

Cedars Sinai Medical Orthopedic

🇺🇸

Los Angeles, California, United States

Harbor-UCLA Medical Center

🇺🇸

Los Angeles, California, United States

Denver Health Medical Center

🇺🇸

Denver, Colorado, United States

University of Chicago

🇺🇸

Chicago, Illinois, United States

University of Kentucky

🇺🇸

Lexington, Kentucky, United States

University of Missouri Health

🇺🇸

Columbia, Missouri, United States

Washington University

🇺🇸

Saint Louis, Missouri, United States

Scroll for more (21 remaining)
University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.